Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,558.57
(
0.51%
)
US TECH 100
29,408.40
(
0.79%
)
Dow Jones
50,658.47
(
0.03%
)
Brent Oil
91.72
(
-0.78%
)
Bitcoin
73,256.15
(
-2.18%
)
News Focus
News Focus
Post# of 257650
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123030
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: masterlongevity post# 73433

Thursday, 02/19/2009 4:18:27 PM

Thursday, February 19, 2009 4:18:27 PM

Post# of 257650
Re: 4Q08 MS worldwide market share by dollar sales (not # of patients)

My calculation of MS market share ($):
copaxone: 30%
avonex: 27%
other interferons: 33%
tysabri: 10%

If you compare your 4Q08 numbers to the 2Q08 numbers in #msg-31152081, two things stand out: i) Copaxone has gained the most share during the past six months; and ii) BIIB has partially undone the precipitous decline in Avonex’s share via aggressive price increases.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today